Research programme: human monoclonal antibodies - Pamlico BiopharmaAlternative Names: IgG monoclonal antibodies - Pamlico
Latest Information Update: 21 Feb 2014
At a glance
- Originator Pamlico Biopharma
- Developer Cytovance Biologics
- Class Monoclonal antibodies
- Mechanism of Action IgG receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Community-acquired pneumonia
Most Recent Events
- 21 Feb 2014 Preclinical trials in Community-acquired pneumonia in USA (Parenteral)